Free Trial

NexGel (NXGL) Stock Price, News & Analysis

NexGel logo
$2.45 +0.11 (+4.70%)
Closing price 08/28/2025 03:59 PM Eastern
Extended Trading
$2.48 +0.03 (+1.43%)
As of 08/28/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About NexGel Stock (NASDAQ:NXGL)

Key Stats

Today's Range
$2.32
$2.54
50-Day Range
$2.22
$2.73
52-Week Range
$2.10
$5.10
Volume
64,445 shs
Average Volume
51,686 shs
Market Capitalization
$19.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

NexGel Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
34th Percentile Overall Score

NXGL MarketRank™: 

NexGel scored higher than 34% of companies evaluated by MarketBeat, and ranked 783rd out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for NexGel.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of NexGel is -6.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of NexGel is -6.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    NexGel has a P/B Ratio of 3.89. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about NexGel's valuation and earnings.
  • Percentage of Shares Shorted

    0.53% of the float of NexGel has been sold short.
  • Short Interest Ratio / Days to Cover

    NexGel has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in NexGel has recently decreased by 43.26%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    NexGel does not currently pay a dividend.

  • Dividend Growth

    NexGel does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.53% of the float of NexGel has been sold short.
  • Short Interest Ratio / Days to Cover

    NexGel has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in NexGel has recently decreased by 43.26%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    NexGel has a news sentiment score of 1.88. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.03 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for NexGel this week, compared to 1 article on an average week.
  • Search Interest

    1 people have searched for NXGL on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, NexGel insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $21,660.00 in company stock.

  • Percentage Held by Insiders

    20.55% of the stock of NexGel is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 2.21% of the stock of NexGel is held by institutions.

  • Read more about NexGel's insider trading history.
Receive NXGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NexGel and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NXGL Stock News Headlines

Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
NEXGEL, Inc. (NXGL) Q2 2025 Earnings Call Transcript
An Overview of NexGel's Earnings
See More Headlines

NXGL Stock Analysis - Frequently Asked Questions

NexGel's stock was trading at $4.46 at the beginning of 2025. Since then, NXGL shares have decreased by 45.1% and is now trading at $2.45.

NexGel, Inc. (NASDAQ:NXGL) issued its quarterly earnings results on Tuesday, August, 12th. The company reported ($0.09) EPS for the quarter, missing analysts' consensus estimates of ($0.07) by $0.02. The firm had revenue of $2.88 million for the quarter, compared to analyst estimates of $3.08 million. NexGel had a negative net margin of 25.02% and a negative trailing twelve-month return on equity of 49.37%.
Read the conference call transcript
.

NexGel (NXGL) raised $14 million in an initial public offering on Wednesday, December 22nd 2021. The company issued 2,100,000 shares at $6.83 per share. Maxim Group LLC acted as the underwriter for the IPO.

NexGel's top institutional investors include Evernest Financial Advisors LLC (3.67%), IFP Advisors Inc (0.14%) and Malaga Cove Capital LLC (0.14%). Insiders that own company stock include John Nachum Stein, Nachum Stein, Adam R Levy, Steven Mark Glassman, Scott Robert Henry, Adam E Drapczuk III and David Stefansky.
View institutional ownership trends
.

Shares of NXGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that NexGel investors own include Lexicon Pharmaceuticals (LXRX), Aditxt (ADTX), Helius Medical Technologies (HSDT), Onconova Therapeutics (ONTX), EchoStar (SATS), American Battery Technology (ABML) and Aumann (AAG).

Company Calendar

Last Earnings
8/12/2025
Today
8/28/2025
Next Earnings (Estimated)
11/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:NXGL
CIK
1468929
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.40)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$3.28 million
Net Margins
-25.02%
Pretax Margin
-24.82%
Return on Equity
-49.37%
Return on Assets
-25.68%

Debt

Debt-to-Equity Ratio
0.16
Current Ratio
1.74
Quick Ratio
0.98

Sales & Book Value

Annual Sales
$8.69 million
Price / Sales
2.27
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.63 per share
Price / Book
3.87

Miscellaneous

Outstanding Shares
8,070,000
Free Float
6,410,000
Market Cap
$19.70 million
Optionable
Not Optionable
Beta
0.57

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:NXGL) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners